Gene · 49
NIH grants1,192
NIH grants whose papers are about the gene, through NIH's grant-paper links.
321 to 340 of 1,192
Download this page as JSON| Grant | Title | ACR papers | Newest fiscal year |
|---|---|---|---|
| UL1TR002240 | Michigan Institute for Clinical and Health Research (MICHR) | 4 | 2022 |
| P30DK081943 | University of Michigan O'Brien Kidney Translational Core Center | 3 | 2022 |
| R01AG027002 | Role of Mitochondrial Health in Acute and Chronic Kidney Disease in Older Adults | 3 | 2022 |
| K08AR072757 | Using the electronic health record to risk-stratify patients with systemic lupus erythematosus | 2 | 2022 |
| P30DK079310 | George M. O'Brien Kidney Center at Yale | 2 | 2022 |
| P30DK079337 | UAB-UCSD O'Brien Center for Acute Kidney Injury Research | 2 | 2022 |
| R01CA213775 | Stromal Fibroblast Autophagy In Tumor Progression and Desmoplasia | 2 | 2022 |
| R01GM105691 | MegaTALS: hyperspecific reagents for targeted gene modification and correction | 2 | 2022 |
| R01NS105845 | Electrophysiological Markers for Interventions in Phelan-McDermid Syndrome and Idiopathic Autism | 2 | 2022 |
| S10OD032293 | High-Throughput Automated Patch Clamp System | 2 | 2022 |
| T32AI007633 | Molecular Basis of Immunity | 2 | 2022 |
| I21RX002870 | Progressive Activity-Based Rehabilitation in Veteran Cancer Survivors with Chronic Pain | 1 | 2022 |
| K01AR075085 | Computational methods using electronic health records and registry data to detect and predict clinical outcomes in rheumatic disease | 1 | 2022 |
| K01HL140146 | Addressing Bias from Missing Data in EHR Based Studies of CVD | 1 | 2022 |
| K23AG058756 | Sarcopenia as a Predictor of Hospital-Associated Disability in Older Adults | 1 | 2022 |
| K23DK114556 | Tubular secretion, kidney disease progression, and drug dosing in older adults | 1 | 2022 |
| K23HL136853 | Blood Pressure Measurement and Hypertension in Pregnancy | 1 | 2022 |
| K24DK092290 | Health Disparities in Chronic Kidney Disease Mentoring Program | 1 | 2022 |
| P01CA210944 | Radiation and checkpoint blockade for cancer immune therapy | 1 | 2022 |
| P01DK117824 | Disordered Tissue Biomechanics as a Driver of Esophageal Disease | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/49/grants?page=17